NCT02500095View on ClinicalTrials.gov

Substrate Metabolism, Growth Hormone Signaling, and Insulin Sensitivity During Fasting

NACompletedINTERVENTIONAL
Enrollment

10

Participants

Timeline

Start Date

July 31, 2015

Primary Completion Date

November 30, 2016

Study Completion Date

November 30, 2016

Conditions
Healthy
Interventions
OTHER

Fasting

72 hours of fasting

DRUG

Saline

Concomitant saline during fasting

DRUG

Pegvisomant

Concomitant Growth hormone receptor blockade with Pegvisomant during fasting

Trial Locations (1)

8000

Aarhus University Hospital, Aarhus

All Listed Sponsors
lead

University of Aarhus

OTHER

NCT02500095 - Substrate Metabolism, Growth Hormone Signaling, and Insulin Sensitivity During Fasting | Biotech Hunter | Biotech Hunter